Clinical Study

Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma

Table 4

Sensitivity and specificity of CA 15-3 for cancer-specific survival (CSS) and progression-free survival.

Sensitivity95% CISpecificity95% CI

CSS83.3%67.2–93.675.3%69.8–80.3
PFS63.4%49.0–76.475.6%69.9–80.7